Purchases and Sales Made in Q3 2022 in Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC) during Q3 2022. The information is specifically focused on institutions that hold shares of Blueprint Medicines Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-232K- 45.8% |
$11.6M - $18.1M
|
275K
$24.9M
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-234K- 13.56% |
$11.7M - $18.2M
|
1.49M
$135M
|
|
|
Oct 27, 2022
Q3 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-399K- 87.05% |
$19.9M - $31M
|
59.4K
$5.38M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-497K- 18.29% |
$24.8M - $38.6M
|
2.22M
$201M
|
|
|
Nov 14, 2022
Q3 2022
|
Cadian Capital Management, LP
New York, NY |
SELL
|
- |
-561K- 27.77% |
$28M - $43.6M
|
1.46M
$132M
|
|
|
Nov 14, 2022
Q3 2022
|
Westfield Capital Management CO LP
Boston, MA |
SELL
|
- |
-581K- 41.97% |
$29M - $45.2M
|
804K
$72.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Healthcare Of Ontario Pension Plan Trust Fund
Toronto, A6 |
SELL
|
- |
-674K- 98.44% |
$33.7M - $52.4M
|
10.7K
$968K
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.6M- 28.41% |
$79.9M - $124M
|
4.03M
$365M
|